RxDoctor Payments Data

Mary Goetsch

Physician Assistant · Gilbert, AZNPI 1083171375

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.4% of the total across 414 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,815 and has fallen 80.6% since, to $546 in 2025. Among physician assistant clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,236in general payments, 2019–2025

Across 414 payments — averaging $22.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Regeneron Healthcare Solutions, Inc.$764
  • Jazz Pharmaceuticals Inc.$621
  • Amgen$616
  • Boehringer Ingelheim$573
  • GSK$559
  • plus $5K from 31 others

What the payments were for

  • Food & beverage$8,71594%
  • Education$5206%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,236 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter193$198,467
Breo ElliptaFluticasone/Vilanterol48$30,220
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$15,055
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$14,902
Fluticasone-SalmeterolFluticasone Propion/Salmeterol61$14,514
Spiriva RespimatTiotropium Bromide14$14,294
SymbicortBudesonide/Formoterol Fumarate26$9,023
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$8,285
Wixela InhubFluticasone Propion/Salmeterol29$7,201
Arnuity ElliptaFluticasone Furoate22$4,677
Albuterol Sulfate HfaAlbuterol Sulfate108$4,355
BreynaBudesonide/Formoterol Fumarate14$3,093
Ventolin HfaAlbuterol Sulfate14$1,233
Azelastine Hcl22$947
Montelukast Sodium62$754

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta$559$241,649276 claims
Boehringer IngelheimStiolto Respimat, Spiriva Respimat$573$29,19625 claims
AstraZenecaBreztri Aerosphere, Symbicort$1,358$24,07837 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Gilbert

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →